Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma.

Authors: Lun, SW  Wong, CK  Ko, FW  Ip, WK  Hui, DS  Lam, CW 
Citation: Lun SW, etal., J Clin Immunol. 2006 Mar;26(2):145-52. Epub 2006 Apr 7.
Pubmed: (View Article at PubMed) PMID:16602032
DOI: Full-text: DOI:10.1007/s10875-006-9003-9

This study further elucidates the roles of selected chemokines (IP-10, MIG, and RANTES) and their receptors (CCR3, CCR5, and CXCR3) in asthma. We compared their profiles in six groups of participants-atopic cohort and nonatopic cohort (each including controls and asthmatic patients with or without steroid therapy). Plasma concentration of IP-10 was significantly lower while that of RANTES and the expression of CCR3 were higher in asthmatic patients (all p < 0.05). Plasma RANTES correlated positively with the GINA severity score in all asthmatic patients (r=0.27, p < 0.05), and with IL-13 in nonatopic asthmatic patients (r=0.46, p < 0.05). In asthmatic patients, the ex vivo release of IP-10 and MIG was attenuated in PBMC activated with allergen, mitogens and IL-18 (p < 0.05). In conclusion, plasma RANTES may be a surrogate marker for asthma and the diminished Th1 related CXC chemokine production may contribute to Th2 predominance in asthma.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 5135457
Created: 2011-07-21
Species: All species
Last Modified: 2011-07-21
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.